Gene: ALDH8A1
Official Full Name: aldehyde dehydrogenase 8 family member A1provided by HGNC
Gene Summary: This gene encodes a member of the aldehyde dehydrogenase family of proteins. The encoded protein has been implicated in the synthesis of 9-cis-retinoic acid and in the breakdown of the amino acid tryptophan. This enzyme converts 9-cis-retinal into the retinoid X receptor ligand 9-cis-retinoic acid, and has approximately 40-fold higher activity with 9-cis-retinal than with all-trans-retinal. In addition, this enzyme has been shown to catalyze the conversion of 2-aminomuconic semialdehyde to 2-aminomuconate in the kynurenine pathway of tryptophan catabolism. [provided by RefSeq, Jul 2018]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19894 | ALDH8A1 Knockout cell line (HeLa) | Human | ALDH8A1 | 1:3~1:6 | Negative | Online Inquiry |
KO19895 | ALDH8A1 Knockout cell line (HCT 116) | Human | ALDH8A1 | 1:2~1:4 | Negative | Online Inquiry |
KO19896 | ALDH8A1 Knockout cell line (HEK293) | Human | ALDH8A1 | 1:3~1:6 | Negative | Online Inquiry |
ALDH8A1 Gene Knockout Cell Lines are genetically engineered cell lines specifically designed to lack the aldehyde dehydrogenase 8A1 enzyme. This enzyme plays a critical role in the metabolism of various aldehydes and the detoxification of harmful substances in cellular processes. By utilizing CRISPR-Cas9 gene editing technology, our ALDH8A1 knockout lines provide researchers with a powerful tool to study the functional consequences of ALDH8A1 ablation, offering insights into cellular pathways related to metabolism, oxidative stress, and cellular proliferation.
The key mechanisms of action involve the targeted disruption of the ALDH8A1 gene, allowing for the examination of aldehyde accumulation and its impact on cellular function. These cell lines are instrumental in elucidating the pathophysiological roles of aldehyde metabolites, particularly in diseases such as cancer, neurodegenerative disorders, and metabolic syndromes. Their use in research can lead to the development of novel therapeutic strategies aimed at overcoming side effects related to aldehyde toxicity.
One of the primary advantages of our ALDH8A1 Gene Knockout Cell Lines lies in their reliability and reproducibility. Unlike traditional cell models, these knockout lines provide a consistent environment for hypothesis testing, ensuring that experimental results are attributed to the deletion of the ALDH8A1 gene itself, rather than variability in cellular responses. Our products are also rigorously validated, providing robust support for researchers in both academia and industry.
For researchers and clinicians, the value of our ALDH8A1 Gene Knockout Cell Lines is clear. They offer a pathway for pioneering research into the consequences of enzymatic dysregulation, which may unlock potential targets for drug development or functional assays. Moreover, utilizing these specialized cell lines can accelerate study timelines, enhance the precision of experimental outcomes, and ultimately contribute to advancing scientific knowledge.
At our company, we pride ourselves on our extensive expertise in genetic engineering and cellular biology. We are dedicated to providing high-quality, customizable biological products that empower researchers and clinicians to push the boundaries of discovery and innovation in their fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.